Comparative protective effect of N-acetyl cysteine and tetramethylpyrazine in rats with gentamicin nephrotoxicity

J Appl Toxicol. 2009 May;29(4):302-7. doi: 10.1002/jat.1409.

Abstract

Gentamicin (GM) is used against serious and life-threatening infections, but its use is limited by the occurrence of nephrotoxicity, which involves the generation of free radicals. In this work we tested the effect of a compound with antioxidant properties, tertamethylpyrazine (TMP), a major constituent of the Chinese medicinal plant Lingusticum wallichi, on GM-induced nephrotoxicity, and compared it with an established anti-oxidant compound N-acetyl cysteine (NAC). Six groups of rats were studied: (1) control, treated orally (p.o.) and intraperitoneally (i.p.) with saline; (2) treated i.p. with GM (80 mg kg(-1) per day for 6 days); (3) TMP, given p.o. (100 mg kg(-1) per day for 10 days) + GM (same dose as above during the last 6 days); (4) NAC, given i.p. (500 mg kg(-1) per day for 10 days) + GM as above; (5) TMP (100 mg kg(-1) per day for 10 days) + saline; (6) NAC (500 mg kg(-1) per day for 10 days) + saline. GM nephrotoxicity was characterized by reduced creatinine clearance, increased creatinine and urea concentrations in plasma, increased urinary excretion of N-acetyl-beta-d-glucosaminidase (NAG) and total protein. These functional and structural alterations were prevented or ameliorated by NAC treatment, while TMP had only a slight mitigating effect that was less marked than that produced by NAC. The concentration of GM in the renal cortex of the rats given GM + NAC (but not TMP) was lower than that found in rats treated with GM alone by about 25%. The mechanism by which NAC and, to a lesser extent TMP, protected against GM-induced nephrotoxicity may be related, at least in part, to the decrease in oxidative stress in renal cortex.

Publication types

  • Comparative Study

MeSH terms

  • Acetylcysteine / pharmacology*
  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / prevention & control*
  • Animals
  • Antioxidants / pharmacology*
  • Body Weight / drug effects
  • Creatinine / metabolism
  • Gentamicins*
  • Kidney Cortex / drug effects
  • Kidney Cortex / metabolism
  • Male
  • Protective Agents*
  • Protein Synthesis Inhibitors*
  • Pyrazines / pharmacology*
  • Rats
  • Rats, Wistar
  • Urea / metabolism
  • Urodynamics / drug effects

Substances

  • Antioxidants
  • Gentamicins
  • Protective Agents
  • Protein Synthesis Inhibitors
  • Pyrazines
  • Urea
  • Creatinine
  • tetramethylpyrazine
  • Acetylcysteine